Related Experiment Video
Updated: May 22, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
The Role of Ferulic Acid in Selected Malignant Neoplasms
Anna Markowska1, Janina Markowska2, Joanna Stanisławiak-Rudowicz3
1Department of Perinatology, Poznań University of Medical Science, 60-535 Poznań, Poland.
Abstract:
Ferulic acid (FA) is a polyphenol that is found in plants and fruits. It has a wide range of anticancer properties, including participating in cell apoptosis, inhibiting invasion and angiogenesis, and acting synergistically with standard cytostatic agents in malignant tumors. A range of molecular mechanisms are involved in anticancer activity and include the following ones: activation of cell-cycle-related proteins and enzymes such as p53, p21, Bax, and pro-caspases 3 and 9, reduction of cyclin D1 and E, proapoptotic Bcl-2, MMP-9, and NF-kV, which decrease VEGF, leading to cell cycle arrest at G0/G1 phase and death of cancer cells. Other mechanisms inhibit several pathways: PI3K/AKT/mTOR, Notch, and Wnt, which are associated with downregulation of proliferation, invasion, metastasis, and angiogenesis. FA can induce activation of ROS, leading to DNA damage in cancer cells. In vitro and in vivo studies have demonstrated the significant antitumor activity of FA in breast cancer, particularly when used in combination with cytostatic agents. In vitro studies on cervical cancer cell lines have reported similar anticancer activity of FA. This includes inhibition of cell proliferation and induction of apoptosis by downregulating antiapoptotic proteins. A case-control study conducted in Italy found that men with histologically confirmed prostate cancer had notably lower levels of FA compared to controls. Molecular in vitro studies have suggested that FA may have various effects on the signaling pathways linked to a reduction in the risk of prostate cancer, and it may act in synergy with δ-tocotrienol, which is a derivative of vitamin E. In vivo and in vitro studies on colorectal cancer have demonstrated the effects of FA on the early development of this cancer-inhibition of abnormal crypt foci (ACF-aberrant crypt foci), as well as the reduction in cancer cell viability and apoptosis through molecular changes, mainly a decrease in EGFR expression. The poor water solubility of FA makes it an attractive candidate for use as nanoparticles.
Insights
Ferulic acid (FA), a plant polyphenol, exhibits anticancer properties by inducing apoptosis and inhibiting cancer cell growth. Studies show its effectiveness against breast, cervical, prostate, and colorectal cancers, often synergizing with other treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ferulic acid (FA) is a naturally occurring polyphenol with demonstrated anticancer potential.
- FA exhibits diverse anticancer activities, including apoptosis induction, inhibition of invasion and angiogenesis, and synergy with chemotherapeutic agents.
- Its molecular mechanisms involve regulating cell-cycle proteins, inhibiting key signaling pathways, and inducing DNA damage via reactive oxygen species (ROS).
Purpose of the Study:
- To review the anticancer properties and molecular mechanisms of ferulic acid.
- To explore the efficacy of FA in various cancer types, including breast, cervical, prostate, and colorectal cancers.
- To highlight FA's potential as a therapeutic agent, considering its synergistic effects and challenges like poor water solubility.
Main Methods:
- Review of in vitro and in vivo studies on ferulic acid's anticancer effects.
- Analysis of molecular mechanisms, including cell cycle regulation, signaling pathway inhibition (PI3K/AKT/mTOR, Notch, Wnt), and ROS induction.
- Examination of FA's efficacy in different cancer models and its combination with other agents.
Main Results:
- FA demonstrated significant antitumor activity in breast, cervical, prostate, and colorectal cancer models.
- Mechanisms include p53 activation, cell cycle arrest at G0/G1, apoptosis induction, and downregulation of proliferation and angiogenesis markers (e.g., VEGF, EGFR).
- FA showed synergistic effects with cytostatic agents and vitamin E derivatives, and potential for nanoparticle formulation.
Conclusions:
- Ferulic acid possesses broad-spectrum anticancer properties mediated by multiple molecular pathways.
- FA shows promise as a chemopreventive and therapeutic agent, particularly in combination therapies.
- Further research, including nanoparticle development, is warranted to optimize FA's clinical application.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation
The Citric Acid Cycle
Drugs that Stabilize Microtubules
Mitogens and the Cell Cycle
Cancer Prevention
Some...